"The whole field of precision medicine and genetic testing
is changing so rapidly. There are new diagnostic tests and therapies emerging
all the time, it seems, and employers aren’t sure what to cover."
— Brian Marcotte, president and CEO of National Business Group
on Health, tells AIS Health about a recent NBGH survey finding that 25% of
employers have no plans to implement initiatives around precision medicine.
No comments:
Post a Comment